617 related articles for article (PubMed ID: 15175075)
1. Protein misfolding in neurodegenerative diseases.
Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
[TBL] [Abstract][Full Text] [Related]
2. Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK; Paul S
FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
[TBL] [Abstract][Full Text] [Related]
3. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
Meredith SC
Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
5. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
[TBL] [Abstract][Full Text] [Related]
6. Developing therapeutics for the diseases of protein misfolding.
May BC; Govaerts C; Cohen FE
Neurology; 2006 Jan; 66(2 Suppl 1):S118-22. PubMed ID: 16432139
[TBL] [Abstract][Full Text] [Related]
7. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.
Wilhelmus MM; van Dam AM; Drukarch B
Eur J Pharmacol; 2008 May; 585(2-3):464-72. PubMed ID: 18417122
[TBL] [Abstract][Full Text] [Related]
9. Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases.
Kim YJ; Takahashi R
Ann N Y Acad Sci; 2006 Nov; 1086():11-20. PubMed ID: 17185502
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of the molecular chaperone Hsp104 from yeast.
Grimminger-Marquardt V; Lashuel HA
Biopolymers; 2010 Mar; 93(3):252-76. PubMed ID: 19768774
[TBL] [Abstract][Full Text] [Related]
11. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
Christen Y
J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
[TBL] [Abstract][Full Text] [Related]
12. [Conformationally altered proteins cause neurodegenerative diseases].
Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
[TBL] [Abstract][Full Text] [Related]
13. Neurodegenerative disease: amyloid pores from pathogenic mutations.
Lashuel HA; Hartley D; Petre BM; Walz T; Lansbury PT
Nature; 2002 Jul; 418(6895):291. PubMed ID: 12124613
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the mysteries of protein folding and misfolding.
Ecroyd H; Carver JA
IUBMB Life; 2008 Dec; 60(12):769-74. PubMed ID: 18767168
[TBL] [Abstract][Full Text] [Related]
16. Modulation of neurodegeneration by molecular chaperones.
Muchowski PJ; Wacker JL
Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
[TBL] [Abstract][Full Text] [Related]
17. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
18. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic strategies for the treatment of protein-misfolding diseases.
Rochet JC
Expert Rev Mol Med; 2007 Jun; 9(17):1-34. PubMed ID: 17597554
[TBL] [Abstract][Full Text] [Related]
20. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.
Forman MS; Trojanowski JQ; Lee VM
Nat Med; 2004 Oct; 10(10):1055-63. PubMed ID: 15459709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
